Immunovant, Inc. (IMVT:NASDAQ) closed at $33.28 on November 16, 2026, down 2.63% on the day. The stock trades 26.7% below its 52-week high of $45.42 and 52.2% above its 52-week low of $21.86. Over the past year, it gained 37.0%. Immunovant, Inc. is part of the Health Care sector.
In 252 trading sessions since November 14, 2025, IMVT closed higher on 122 days (48%). Its best day was May 20, 2026 (+35.26%) and its worst was September 23, 2026 (-7.37%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 2 times.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn).
Find more stocks like IMVT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.